Metabolic Alterations in Renal and Prostate Cancer

E-ISSN： 1875-5453|17|2|150-155

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.17, Iss.2, 2016-02, pp. : 150-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic and toxicological considerations of newly approved prostate cancer drugs

By Tsao Che-Kai Liaw Bobby Yee Tiffany Galsky Matthew D Oh William K

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 7, 2013-07 ,pp. : 835-846

Informa Healthcare

Access to resources Recommend Favorite

Zoledronic acid to prevent SREs in prostate, renal cancer cost effective

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 578, 2009-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Prostate Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 7, 2007-08 ,pp. : 650-650

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Metabolic Effects of Renal Denervation

Current Clinical Pharmacology, Vol. 8, Iss. 3, 2013-01 ,pp. : 206-211

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic alterations and chronic hepatitis C: treatment strategies

By Adinolfi Luigi E Restivo Luciano Zampino Rosa Lonardo Amedeo Loria Paola

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2215-2234

Informa Healthcare

Access to resources Recommend Favorite